Cognitive Reappraisal Intervention for Suicide Prevention for Suicide Prevention
Weill Cornell Institute of Geriatric Psychiatry, Weill Cornell Medicine, White Plains, NY
Targeting 2 different conditionsCognitive Reappraisal Intervention for Suicide Prevention +1 moreN/ARecruitingLed by Dimitris Kiosses, PhDResearch Sponsored by Weill Medical College of Cornell UniversityEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients with any degree of suicidal ideation at discharge (Columbia Suicide Severity Rating greater or equal to 0) will be included.
Diagnosis (based on SCID-5 Clinical Trials Version to assess DSM-5 diagnoses): Any DSM-5 depression or anxiety diagnosis, including major depressive disorder, bipolar depression, depressive disorder Not Elsewhere Classified, anxiety disorder Not Elsewhere Classified, adjustment disorder with anxiety and depressed mood (but without any of the diagnoses shown under Exclusion Criteria)
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upbaseline, 6, 12, and 24 weeks
Awards & highlights
No Placebo-Only Group
Study Summary
This trial is testing a new intervention to reduce suicide risk for adults aged 50-90 who have been hospitalized for suicidal thoughts or attempts.
Eligible Conditions
- Suicide Prevention
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You do not have any thoughts about hurting yourself or committing suicide.
Select...
You have been diagnosed with depression or anxiety as defined by the DSM-5 (a medical manual for mental health conditions). This includes different types of depression and anxiety disorders, but not specific types that are listed under exclusion criteria.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 6, 12, and 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 6, 12, and 24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Emotion Regulation, as measured by the Electroencephalogram (EEG), Autobiographical Affective Regulation Task (AART), and a standard picture-based emotion regulation task.
Other outcome measures
Change in Suicide Severity, as measured by the Columbia Suicide Severity Rating Scale (CSSR-S)
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: CRISPExperimental Treatment1 Intervention
Cognitive Reappraisal Intervention for Suicide Prevention (CRISP) is a psychosocial intervention aimed to reduce suicide risk in middle-aged and older adults who have been hospitalized for suicidal ideation or suicide attempt. CRISP offers a combination of emotion regulation techniques, including changing the subject's perspective or the way he/she thinks to improve emotion reactions. Additional strategies taught include the provision of environmental adaptation tools (notes, checklists, calendars, etc), phone calls, and a tablet application called WellPATH.
Group II: Supportive Therapy (ST)Active Control1 Intervention
Supportive Therapy focuses on: 1. facilitating expression of affect; 2. conveying to the patient that he or she is understood; 3. offering empathy; and 4. highlighting positive experiences. The ST manual aims to standardize nonspecific therapeutic factors.
Find a site
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,025 Previous Clinical Trials
1,319,526 Total Patients Enrolled
Stanford UniversityOTHER
2,258 Previous Clinical Trials
17,273,550 Total Patients Enrolled
Florida State UniversityOTHER
181 Previous Clinical Trials
29,420 Total Patients Enrolled
2 Trials studying Suicide Prevention
130 Patients Enrolled for Suicide Prevention
National Institute of Mental Health (NIMH)NIH
2,668 Previous Clinical Trials
1,985,716 Total Patients Enrolled
21 Trials studying Suicide Prevention
119,895 Patients Enrolled for Suicide Prevention
Rutgers UniversityOTHER
105 Previous Clinical Trials
2,801,290 Total Patients Enrolled
1 Trials studying Suicide Prevention
60 Patients Enrolled for Suicide Prevention
Dimitris Kiosses, PhDPrincipal Investigator
Weill Medical College of Cornell University6 Previous Clinical Trials
525 Total Patients Enrolled
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available for potential participants of this medical experiment?
"Affirmative. According to clinicaltrials.gov, the research is accepting new participants and was first posted on March 28th 2017 with a recent update on May 17th 2022. The trial needs 90 individuals from one centre to take part in this investigation."
Answered by AI
Does the age of applicants have any bearing on eligibility for this clinical experiment?
"This medical trial requires patients to be between the ages of 50 and 90. In contrast, there are 57 trials for those younger than 18 years old and 117 for seniors exceeding 65 years of age."
Answered by AI
How many participants are receiving treatment through this clinical trial?
"Affirmative. Patient recruitment for this clinical trial is ongoing, as seen on the listing posted to clinicaltrials.gov dated March 28th 2017 and updated May 17th 2022. This experiment needs 90 participants from a single medical center."
Answered by AI
Am I able to enroll in this experiment?
"This medical trial seeks 90 elderly individuals aged between 50 and 90 who are suffering from depression or anxiety. The DSM-5 diagnosis criteria (from the SCID-5 Clinical Trials Version) must be used to determine patient eligibility."
Answered by AI